US EditionPublished • loading... • Updated
Weight-Loss Drugs Market 'Almost Like Viagra': Pfizer Boss
Pfizer plans 10 phase 3 trials for Metsera obesity drugs as cash-pay sales grow rapidly, mirroring Viagra's early market, CEO Albert Bourla said.
Summary by Otago Daily Times
4 Articles
4 Articles
“We are betting everything on obesity,” said CEO Albert Bourla. “We have invested. We have good commercial expertise, good development expertise, and good discovery expertise.”
·Brazil
Read Full Article
Pfizer stock dips as CEO says obesity-drug cash-pay demand looks “almost like Viagra”
New York, January 12, 2026, 20:17 (EST) — Market closed. Pfizer Inc. shares fell on Monday after Chief Executive Albert Bourla said the cash-pay market for obesity drugs — where patients pay out of pocket — now works “almost like Viagra”, the erectile-dysfunction drug Pfizer launched in 1998. The company, which bought obesity developer Metsera in a deal valued at up to $10 billion and has said it does not expect to return to revenue growth until…
Coverage Details
Total News Sources4
Leaning Left0Leaning Right1Center2Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
C 67%
R 33%
Factuality
To view factuality data please Upgrade to Premium
